US FDA finalizes SOP on communicating immediate changes in medtech reg expectations
28 March 2014
- Report calls for more US FDA scrutiny on increase in device submission withdrawals
- US FDA improves and expands early feedback mechanisms for medtech
- US industry fears more devices will get rustled down PMA route with device classification changes
- FDA digital health regs: 'smart' or innovation killer?
Other Informa News